Pharmacological agents for the prevention and treatment of toxic radiation exposure in spaceflight

Aviation Space and Environmental Medicine

Volumn 79, Issue 7, 2008, Pages 651-660

  Langell, John ^a   Jennings, Richard ^b   Clark, Jonathan ^c   Ward Jr , Jonathan B ^b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c National Space Biomedical Research Institute   (United States)

Author keywords

Galactic cosmic radiation; High energy particles; Ionizing radiation; Radiopharmacology; Radiotherapeutic; Solar particle events

Indexed keywords

2 MERCAPTOPROPIANYLGLYCINE; 5 ANDROSTENENDIOL; AMIFOSTINE; COPPER; DILTIAZEM; GLUCAN; IRON; MANGANESE; MELATONIN; MINT EXTRACT; NIFEDIPINE; RADIOPROTECTIVE AGENT; SELENIUM; TRIPHALA; ZINC;

COSMIC RADIATION; DRUG MEGADOSE; FOOD AND DRUG ADMINISTRATION; HEAD AND NECK CANCER; HUMAN; MEDICAL LITERATURE; MEDLINE; NONHUMAN; RADIATION DETECTION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION; RADIATION TOXICITY; REVIEW; SPACE FLIGHT; STOMATITIS; TOXICITY;

ANIMALS; COSMIC RADIATION; HUMANS; RADIATION DOSAGE; RADIATION INJURIES; RADIATION PROTECTION; RADIATION-PROTECTIVE AGENTS; SOLAR ACTIVITY; SPACE FLIGHT;

EID: 46249125288     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: 10.3357/ASEM.2113.2008     Document Type: Review

References (78)

1. Agarwal K, Sharma A, Talukder G. Effects of copper on mammalian cell components. Chem Biol Interact 1989; 69:1-16.
2. Berg JM. Zinc fingers: the role of zinc(II) in transcription factor IIIA and related proteins. Met Ions in Biol Sys 1989; 25:235-54.
3. Blickenstaff RT, Brandstadter SM, Reddy S, Witt R. Potential radioprotective agents. I. Homologues of melatonin. J Pharm Sci 1994; 83:216-8.
4. Bohuslavizki KH, Klutmann S, Brenner W. Salivary gland protection by amifostine in high-dose radiation treatment: results of a double-blind placebo-controlled study. J Clin Oncol 1998; 16:3542-9.
5. Bohuslavizki KH, Klutmann S, Jenicke L. Radioprotection of salivary glands by S-2-(3-aminopropylamin)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model. Int J Radiat Oncol Biol Phys 1999; 45:181-6.
6. Broeder CE, Quindry J, Brittingham K, Panton L, Thomsom J, Appakondu S, et al. Physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Arch Intern Med 2000; 160:3093-104.
7. Combs GF, Gray WP. Chemopreventive agents: selenium. Pharmacol Ther 1998; 79:179-92.
8. Daffada AAI, Young SP. Coordinated regulation of ceruloplasmin and metallothionein mRNA by interleukin-1 and copper in hepG2 cells. FEBS Lett 1999; 457:214-8.
9. Dons RF, Fohlmeister U. Combined injury syndrome in space-related radiation environments. Adv Space Res 1992; 12:157-63.
10. Edwards AA. RBE of radiations in space and implications for space travel. Phys Med 2001; 17(Suppl. 1):147-52.
11. st ed. Philadelphia: WB Saunders; 2001.
12. Floersheim GL. Calcium antagonists protect mice against lethal doses of ionizing radiation. Br J Radiol 1992; 65:1025-9.
13. Floersheim GL. Radioprotective effects of calcium antagonists used alone or with other types of radioprotectors. Radiat Res 1993; 133:80-7.
14. Floersheim GL, Floersheim P. Protection against ionising radiation and synergism with thiols by zinc aspartate. Br J Radiol 1986; 59:597-602.
15. Fry SA, Net R, Weiss JF, Jarrett DG, Thomassen D, Seed TM. Prevention and treatments summary. Mil Med 2002; 167(Suppl. 1):87-93.
16. Grdina DJ, Murley JS, Kataoka Y. Radioprotectants: current status and new directions. Oncology 2002; 63(Suppl. 2):2-10.
17. Guan J, Wan XS, Zhou Z, Ware J, Donahue JJ, Biaglow JE, et al. Effects of dietary supplements on space radiation-induced oxidative stress in Sprague-Dawley rats. Radiat Res 2004; 162:572-9.
18. 6 in γ-irradiated mice. Inflammopharmacology 1995; 3:241-50.
19. Hospers GAP, Eisenhauer EA, de Vries EGE. The sulfhydryl containing compounds WR-2721 and glutathione as radio-and chemoprotective agents. A review, indications for use and prospects. Br J Cancer 1999; 80:629-38.
20. Hunt DWC, Sorrenti RA, Renke ME, Xie LY, Waterfield EM, Levy JG. Effect of porphyrins on the hematopoietic recovery of mice treated with gamma-radiation. Immunopharmacol Immonotoxicol 1994; 16:55-70.
21. 2. Inflammopharmacology 1995; 3:251-7.
22. 6. Inflammopharmacology 1996; 4:309-21.
23. Jagetia GC, Baliga MS. Influence of the leaf extract of Mentha arvensis Linn. (mint) on the survival of mice exposed to different doses of gamma radiation. Strahlenther Onkol 2002; 178:91-8.
24. Jagetia GC, Baliga MS, Malagi KJ, Kamath MS. The evaluation of the radioprotective effect of triphala (an ayurvedic rejuvenating drug) in the mice exposed to gamma-radiation. Phytomedicine 2002; 9:99-108.
25. Karbownik M, Reiter RJ. Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med 2000; 225:9-22.
26. Kumar KS, Srinivasan V, Toles R, Jobe L, Seed TM. Nutritional approaches to radioprotection: vitamin E. Mil Med 2002; 167(Suppl. 1):57-9.
27. Letaw JR. Radiation biology. In: Churchill SE, ed. Fundamentals of space life sciences. Malabar, FL: Krieger Publishing; 1997:11-18.
28. Levander OA. Nutrition and newly emerging viral diseases: an overview. J Nutr 1997; 127:948S-50S.
29. Lindegaard JC, Grau C. Has the outlook improved for amifostine as a clinical radioprotector. Radiother Oncol 2000; 57:113-8.
30. Matsubara J, Tajima Y, Karasawa M. Promotion of radioresistance by metallothionein induction prior to irradiation. Environ Res 1987; 43:66-74.
31. McConnell KW, Muenzer JT, Chang KC, Davis CG, McDunn JE, Coopersmith CM, et al. Anti-apoptotic peptides protect against radiation-induced cell death. Biochem Biophys Res Commun 2007; 355:501-7.
32. Milas L, Nishiguchi I, Hunter N, Murray D, Fleck R, Ito H, et al. Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin. Adv Space Res 1992; 12:265-71.
33. NRCP (National Council on Radiation Protection and Measurements USA). NRCP Report no. 132. Bethesda, MD: NRCP; 2001.
34. th ed. Washington, DC: National Academy Press; 1989.
35. Noaman E, Zahran AM, Kamal AM, Omran MF. Vitamin E and selenium administration as a modulator of antioxidant defense system: biochemical assessment and modification. Biol Trace Elem Res 2002; 86:55-64.
36. Osiris Therapeutics awarded Department of Defense contract for prochymal ™fully valued at $224.7 million. 2008; Retrieved 8 Feb. 2008 from: Http://www.osiristx.com/pdf/PR%2065%2003Jan08%20Osiris%20Wins%20DoD%20Contract. pdf
37. Patchen ML, Lotzova E. Modulation of murine hemopoiesis by glucan. Exp Hematol 1980; 8:409-22.
38. Patchen ML, MacVittie TJ. Dose-dependent responses of murine pluripotent stem cells and myeloid and erythroid progenitor cells following administration of the immunomodulating agent glucan. Immunopharmacology 1983; 5:303-13.
39. Patchen ML, MacVittie TJ, Solberg BD, D'Alesandro MM, Brook I. Radioprotection by polysaccharides alone and in combination with aminothiols. Adv Space Res 1992; 12:233-48.
40. Patchen ML, MacVittie TJ, Weiss JF. Combined modality radioprotection: the use of glucan and selenium with WR-2721. Int J Radiat Oncol Biol Phys 1990; 18:1069-75.
41. Prasanna PGS, Devi PU. Modification of WR-2721 radiation protection from gastrointestinal injury and death in mice by 2-mercaptopropionylglycine. Radiat Res 1993; 133:111-5.
42. Purohit A, Woo LW, Chander SK, Newman SP, Ireson C, Grasso A, et al. Steroid sulphatase inhibitors for breast cancer therapy. J Steroid Biochem Mol Biol 2003; 86:423-32.
43. Rajagopalan R, Wani K, Huilgol NG, Kagiya TV, Nair CK. Inhibition of gamma-radiation induced DNA damage in plasmid pBR322 by TMG, a water-soluble derivative of vitamin E. J Radiat Res (Tokyo) 2002; 43:153-9.
44. Reiss GR, Langell JT, DiSesa VJ, Prockop DJ. Rescue from lethal total body irradiation by allogenic marrow stromal cells. Surg Forum 1998; 44:392-4.
45. Rust DM. Solar flares: an overview. Adv Space Res 1992; 12:289-301.
46. Samman MA, Bowen ID, Taiba K, Antonius J, Hannan MA. Mint prevents shamma-induced carcinogenesis in hamster cheek pouch. Carcinogenesis 1998; 19:1795-801.
47. Satyamitra M, Devi UP, Murase H, Kagiya VT. In vivo post-irradiation protection by a vitamin E analog, alpha-TMG. Radiat Res 2003; 160:655-61.
48. Seed T, Kumar S, Whitnall MH, Srinivasan V, Singh V, Elliott T, et al. New strategies for the prevention of radiation injury: possible implications for countering radiation hazards of long-term space travel. J Radiat Res (Tokyo) 2002; 43:S239-44.
49. Shiraishi N, Aono K, Utsumi K. Increased metallothionein content in rat liver induced by X irradiation and exposure to high oxygen tension. Radiat Res 1983; 95:298-302.
50. Singh VK, Shafran RL, Inal CE, Jackson WE, Whitnall MH. Effects of whole-body gamma irradiation and 5-androstendiol administration on serum G-CSF. Immunopharmacol Immunotoxicol 2005; 27:521-34.
51. Singh VK, Shafran RL, Jackson WE, Seed TM, Kumar KS. Induction of cytokines by radioprotective tocopherol analogs. Exp Mol Pathol 2006; 81:55-61.
52. Soderberg LS, Barnett JB, Baker ML, Chang LW, Salari H, Sorenson JR. Copper(II)2(3,5-diisopropylsalicylate)4 stimulates hematopoiesis in normal and irradiated mice. Exp Hematol 1988; 16:577-80.
53. Soderberg LS, Barnett JB, Baker ML, Salari H, Sorenson JR. Copper(II)(3,5-diisopropylsalicylate)2 accelerates recovery of B and T cell reactivity following irradiation. Scand J Immunol 1987; 26:495-502.
54. Soderberg LS, Barnett JB, Baker ML, Salari H, Sorenson JR. Postirradiation treatment with copper(II)2(3,5-diisopropylsalicylate)4 enhances radiation recovery and hematopoietic regeneration. Exp Hematol 1990; 18:801-5.
55. Soderberg LS, Barnett JB, Sorenson JR. Copper complexes stimulate hemopoiesis and lymphopoiesis. Adv Exp Med Biol 1989; 258:209-17.
56. Sorenson JRJ. Cu, Fe, Mn, and Zn chelates offer a medicinal chemistry approach to overcoming radiation injury. Curr Med Chem 2002; 9:639-62.
57. Sorenson JR. Bis(3,5-diisopropylsalicylato)copper(II), a potent radioprotectant with superoxide dismutase activity. J Med Chem 1984; 27:1747-9.
58. Sorenson JJ, Soderberg LS, Baker ML, Barnett JB, Chang LW, Salari H, et al. Radiorecovery agents: Cu(II), Mn(II), Zn(II), or Fe(III) 3,5-diisopropylsalicylate complexes facilitate recovery from ionizing radiation induced radical mediated tissue damage. Adv Exp Med Biol 1990; 264:69-77.
59. Sorenson JR, Soderberg LS, Chang LW. Radiation protection and radiation recovery with essential metalloelement chelates. Proc Soc Exp Biol Med 1995; 210:191-204.
60. Sorenson JRJ, Soderberg LSF, Chang LW, Willingham WM, Baker ML, Barnett JB, et al. Copper-, iron-, manganese-, and zinc-3,5-diisopropylsalicylate complexes increase survival of gamma-irradiated mice. Eur J Med Chem 1993; 28:221-9.
61. Stewart J, Ware J, Fortina P, Breaux J, Gulati S, Kennedy A. L-selenomethianine modulates high LET radiation-induced alterations of gene expression in cultured human thyroid cells. Oncol Rep 2006; 16:569-74.
62. Stickney DR, Dowding C, Authier S, Garsd A, Onizuka-Handa N, Reading C, et al. 5-androstenediol improves survival in clinically unsupported Rhesus monkeys with radiation-induced myelosuppression. Int Immunopharmacol 2007; 7:500-5.
63. Suriyachan D, Patarakitvanit S, Ratananakorn P. Radioprotective effect of copper(II)2(3,5-diisopropylsalicylate)4 in rats. Royal Thai Army Medical Journal 1989; 42:145-8.
64. th ed. Baltimore, MD: Williams and Wilkens; 1999:347-362.
65. Traber MG, Packer L, Vitamin E. Beyond antioxidant function. Am J Clin Nutr 1995; 62:1501S-9S.
66. Turner JE. Chemical and biological effects of radiation. In: Turner JE. Atoms, radiation, and radiation protection. New York: Pergamon Press; 1996:217-43.
67. Upton AC. The biological effects of low-level ionizing radiation. Sci Am 1982; 246:41-9.
68. Waknine Y. New FDA orphan drugs: cellcept, prochymal, shiga toxin antibodies. Medscape Medical News. Jan 9, 2006. Available at http://www.medscape.com/viewarticle/521133.
69. Wan XS, Ware JH, Zhou Z, Donahue JJ, Guan J, Kennedy AR. Protection against radiation-induced oxidative stress in cultured human epithelial cells by treatment with antioxidant agents. Int J Radiat Oncol Biol Phys 2006; 64:1475-81.
70. Weiss JF, Kumar KS, Walden TL, Neta R, Landauer MR, Clark EP. Advances in radioprotection through the use of combined agent regimens. Int J Radiat Biol 1990; 57:709-22.
71. Weiss JF, Srinivansan V, Kumar KS, Landauer MR. Radioprotection by metals: selenium. Adv Space Res 1992; 12:223-31.
72. Whitnall MH, Elliott TB, Landauer MR, Jackson WE 3rd, Wilhelmsen CL, Mckinney L, et al. In vivo protection against gamma-irradiation with 5-androstenediol. Exp Biol Med (Maywood) 2001; 226:625-7.
73. Whitnall MH, Eliott TB, Landauer MR, Wilhelmsen CL, McKinney L, Kumar KS, et al. Protection against gamma-irradiation with 5-androstenediol. Mil Med 2002; 167(Suppl. 1):64-5.
74. Whitnall MH, Wilhelmsen CL, McKinney L, Miner V, Seed TM, Jackson WE. Radioprotective efficacy and acute toxicity of 5-androstenediol after subcutaneous or oral administration in mice. Immunopharmacol Immunotoxicol 2002; 24:595-626.
75. Wilson JW, Cucinotta FA, Kim MH, Schmmerling W. Optimized shielding for space radiation protection. Phys Med 2001; 17(Suppl. 1):67-71.
76. Xiao M, Inal CE, Parekh VI, Chang C, Whitnall MH. 5-Androstendiol promotes survival of gamma-irradiated human hematopoietic progenitors through induction of nuclear factor-kappaB activation and granulocyte colony-stimulating factor activation and granulocyte colony-stimulating factor expression. Mol Pharmacol 2007; 72:370-9.
77. Yuhas JM, Afzal SMF, Afzal V. Variation in normal tissue responsiveness to WR-2721. Int J Radiat Oncol Biol Phys 1984; 10:1537-9.
78. Zenk JL. New therapy for the prevention and prophylactic treatment of acute radiation syndrome. Expert Opin Investig Drugs 2007; 16:767-70.